Asherman综合征患者胚胎移植前子宫内膜厚度测量
本研究为回顾性队列研究,纳入45例Asherman综合征(AS)患者共90次胚胎移植(ET),分析移植前最大子宫内膜厚度(EMT)与临床妊娠率的关系。结果显示EMT测量值可能与非AS人群不同,与临床妊娠无显著关联;EMT<7.0mm与≥7.0mm组临床妊娠率无差异(P=0.83)。
要点
- AS患者ET前平均EMT为7.5±1.6mm,31.8%测量值<7.0mm。
- EMT测量值未预测临床妊娠(双变量P=0.84;多变量OR 0.91,P=0.60)。
- 年轻患者年龄(P=0.05)和供卵(P=0.01)是临床妊娠的显著预测因素。
核心结论
- 在Asherman综合征患者中,胚胎移植前子宫内膜厚度测量可能不与临床妊娠成功相关。
研究设计与样本
- 回顾性队列研究,纳入2015年1月1日至2019年3月1日期间在专门高级宫腔镜诊所治疗的45例Asherman综合征患者,共90次胚胎移植。
主要发现
- 45例患者中25例(55.6%)在平均2.00±1.26次移植尝试后获得至少1次临床妊娠。
- 90次胚胎移植中29次(32.2%)导致临床妊娠。
- 移植前平均EMT为7.5±1.6mm;31.8%的测量值<7.0mm。
- EMT<7.0mm与≥7.0mm组临床妊娠率无差异(P=0.83)。
- 平均EMT随AS疾病严重程度增加而降低:轻度8.0±1.6mm,中度7.0±1.4mm,重度5.4±0.1mm。
关键数值与推荐
- 双变量分析中,年轻患者年龄(P=0.05)和供卵(P=0.01)是临床妊娠的显著预测因素。
- EMT测量值在双变量(P=0.84)和多变量分析(OR 0.91,P=0.60)中均未预测临床妊娠。
临床怎么用
- 在AS患者中取消预定胚胎移植时,应谨慎使用EMT截断值。
局限性
- 样本量小,限制得出 definitive 结论的能力。
- 患者使用不同不孕症诊所,限制评估EMT测量一致性和接受的IVF护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there an association between endometrial thickness (EMT) measurement and clinical pregnancy rate among Asherman syndrome (AS) patients utilizing IVF and embryo transfer (ET)? SUMMARY ANSWER: EMT measurements may not be associated with successful clinical pregnancy among AS patients undergoing IVF. WHAT IS KNOWN ALREADY: Clinical pregnancy rate after IVF is significantly lower in patients with a thin endometrium, defined as a maximum EMT of <7 mm. However, AS patients often have a thin EMT measurement due to intrauterine scarring, with a paucity of data and no guidance on what EMT cutoff is appropriate when planning an ET among these patients. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study of 45 AS patients treated at a specialized advanced hysteroscopic clinic from 1 January 2015, to 1 March 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS: Review of EMT measurements prior to a total of 90 ETs, among 45 AS patients. The impact of the maximum EMT measurement prior to ET on clinical pregnancy rate was analyzed. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 25/45 (55.6%) AS patients ultimately went on to have ≥1 clinical pregnancy following a mean ± SD of 2.00 ± 1.26 ET attempts. There was a total of 90 ETs among the 45 AS patients, with 29/90 (32.2%) ETs resulting in a clinical pregnancy. Younger patient age (P = 0.05) and oocyte donation (P = 0.01) were the only variables identified to be significant predictors for a positive clinical pregnancy outcome on bivariate analysis. The mean EMT measurement prior to all ETs among AS patients was 7.5 ± 1.6 mm. EMT measurement prior to ET did not predict a positive clinical pregnancy on either bivariate (P = 0.84) or multivariable analysis (odds ratio 0.91, P = 0.60). 31.8% of EMT measurements measured <7.0 mm. In this small cohort, no difference in the clinical pregnancy rate was detected when comparing ETs with EMT measurements of <7.0 mm versus ≥7.0 mm (P = 0.83). The mean EMT measurement decreased with increasing AS disease severity; 8.0 ± 1.6 mm for mild disease, 7.0 ± 1.4 mm for moderate disease and 5.4 ± 0.1 mm for severe disease. LIMITATIONS, REASONS FOR CAUTION: Our small sample size limits our ability to draw any definitive conclusions. In addition, patients utilized various infertility clinics. This limits our ability to evaluate the consistency of EMT measurements and the IVF care that was received. WIDER IMPLICATIONS OF THE FINDINGS: EMT measurement cutoff values should be used with caution if canceling a scheduled ET in AS patients. STUDY FUNDING/COMPETING INTEREST(S): This study was not funded. K.I. reports personal fees from Karl Stroz and personal fees from Medtronics outside the submitted work. The other authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Movilla P, Wang J, Chen T, et al. Endometrial thickness measurements among Asherman syndrome patients prior to embryo transfer. Hum Reprod. 2020. PMID: 33083829. doi:10.1093/humrep/deaa273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。